Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Remix Therapeutics logo — Reprogramming RNA Processing, Designing Therapeutic Solution...

Remix Therapeutics

Reprogramming RNA Processing, Designing Therapeutic Solutions

Founded 2018 United States United States 67 employees Venture round Total: $211.00M Biotechnology, Health Care +1

General Information

Company Name Remix Therapeutics
Founded Year 2018
Location United States United States
Employees 67
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Remix Therapeutics. To contact Remix Therapeutics, visit remixtx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Remix Therapeutics compare?

A PDF of Remix Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Remix Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Remix Therapeutics

Remix Therapeutics is a biotechnology startup founded in 2019 with a clear mission to reprogram RNA processing, ultimately designing therapeutic solutions. Their breakthrough science focuses on identifying small molecules that can impact the expression of disease-driving mRNAs and proteins. The company is dedicated to addressing drug targets in high unmet medical need diseases, demonstrating a commitment to scientific integrity and urgency in delivering new therapeutic options to patients. Based in the United States, Remix has rapidly generated multiple drug discovery programs through its in-house technology platform, which was built from scratch. The startup recently secured $60.00M in Venture Round investment in January 2024. This investment was backed by a notable group of investors including Arch Venture Partners, Atlas Venture, Casdin Capital, The Column Group, Alexandria Venture Investments, Foresite Capital, Willett Advisors, Surveyor Capital, and WTT Investment. With this support, Remix Therapeutics is well-positioned to advance its drug discovery programs towards clinical development, solidifying its presence in the biotechnology and healthcare industries.

Business keywords: RNA processing, Therapeutic solutions, Drug discovery, Medical research, Small molecule drugs, Disease treatment, Clinical advancements

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $60.00M 9
Arch Venture Partners Atlas Venture Casdin Capital
Arch Venture Partners, Atlas Venture +7
03 Jan 2024
Series B $70.00M 1
Atlas Venture
Atlas Venture
17 May 2022
Series A $65.00M -
08 Dec 2020
Seed Round $16.00M -
01 Jan 2019

Remix Therapeutics Alternatives & Competitors

View All Alternatives
Remix Therapeutics vs
Reborna Biosciences, Inc.
Reborna Biosciences, Inc. Japan

Save the life of rare disease patients and the parents by RNA binding molecules.

Seed
7 employees
Biotechnology, Health Care
Compare Remix Therapeutics vs Reborna Biosciences, Inc.
Remix Therapeutics vs
Inspirna, Inc.
Inspirna, Inc. United States

Converting cancer to a manageable, chronic condition

Series D
12 employees
Biotechnology, Health Care
Compare Remix Therapeutics vs Inspirna, Inc.
Remix Therapeutics vs
Ribometrix Inc.
Ribometrix Inc. United States

Combining the proven power of small molecules with the promise of RNA targeting to create a new clas...

14 employees
Biotechnology, Health Care
View all alternatives

FAQ About Remix Therapeutics

Reprogramming RNA Processing, Designing Therapeutic Solutions
Remix Therapeutics was founded in 2018.
Remix Therapeutics is headquartered in United States.
Remix Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on RNA processing, Therapeutic solutions, Drug discovery and Medical research.
Remix Therapeutics has approximately 67 employees.
Remix Therapeutics has completed 4 funding rounds, raising a total of $211.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Remix Therapeutics include Reborna Biosciences, Inc., Inspirna, Inc., Ribometrix Inc., Rgenta Therapeutics Inc., Developing New Drugs for AML and PDAC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Remix Therapeutics and Reborna Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Remix Therapeutics, https://bouncewatch.com/company/remix-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout